165 related articles for article (PubMed ID: 7743597)
21. Central role of interleukin-15 in human immunodeficiency virus (HIV)-infected patients with visceral leishmaniasis.
d'Ettorre G; Ceccarelli G; Carnevalini M; Forcina G; Zaffiri L; Massetti AP; Mastroianni CM; Vullo V
Acta Trop; 2006 Aug; 99(1):83-7. PubMed ID: 16962979
[TBL] [Abstract][Full Text] [Related]
22. [Leishmania infection and AIDS].
Hernández Quero J; Carvajal Becerra F; Escobar Lara T; López Ruz MA; Vélez Bernal ID; de La Higuera JM
An Med Interna; 1993 Jun; 10 Suppl():29-33. PubMed ID: 8507799
[No Abstract] [Full Text] [Related]
23. [Visceral leishmaniasis and HIV infection in the HAART era].
Marques N; Cabral S; Sá R; Coelho F; Oliveira J; Saraiva da Cunha JG; Meliço Silvestre A
Acta Med Port; 2007; 20(4):291-8. PubMed ID: 18198072
[TBL] [Abstract][Full Text] [Related]
24. Leishmania infection occurring in herpes zoster lesions in an HIV-positive patient.
Barrio J; Lecona M; Cosin J; Olalquiaga FJ; Hernanz JM; Soto J
Br J Dermatol; 1996 Jan; 134(1):164-6. PubMed ID: 8745907
[TBL] [Abstract][Full Text] [Related]
25. Elevated levels of soluble non-classical major histocompatibility class I molecule human leucocyte antigen (HLA)-G in the blood of HIV-infected patients with or without visceral leishmaniasis.
Donaghy L; Gros F; Amiot L; Mary C; Maillard A; Guiguen C; Gangneux JP
Clin Exp Immunol; 2007 Feb; 147(2):236-40. PubMed ID: 17223963
[TBL] [Abstract][Full Text] [Related]
26. Cutaneous leishmaniasis associated with visceral leishmaniasis in a case of acquired immunodeficiency syndrome (AIDS).
Pourahmad M; Hooshmand F; Rahiminejad M
Int J Dermatol; 2009 Jan; 48(1):59-61. PubMed ID: 19126052
[TBL] [Abstract][Full Text] [Related]
27. [Visceral leishmaniasis in patients with HIV infection. Our experience].
Terra L; Pellicanò S; Allò M
Minerva Med; 1996 Jun; 87(6):317-9. PubMed ID: 8700361
[TBL] [Abstract][Full Text] [Related]
28. [Parasite identification in the surveillance of imported leishmaniasis cases in Italy].
Gramiccia M; Di Muccio T; Marinucci M
Parassitologia; 2004 Jun; 46(1-2):207-10. PubMed ID: 15305718
[TBL] [Abstract][Full Text] [Related]
29. Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial.
Lemesre JL; Holzmuller P; Gonçalves RB; Bourdoiseau G; Hugnet C; Cavaleyra M; Papierok G
Vaccine; 2007 May; 25(21):4223-34. PubMed ID: 17395339
[TBL] [Abstract][Full Text] [Related]
30. [The clinical and evolutional characteristics of visceral leishmaniasis in patients with HIV infection].
Delgado Fernández M; García Ordoñez MA; Martos Pérez F; Reguera Iglesias JM; Jiménez Oñate F; Colmenero Castillo JD
An Med Interna; 1997 Oct; 14(10):506-10. PubMed ID: 9424140
[TBL] [Abstract][Full Text] [Related]
31. Leishmania / HIV co-infections.
Desjeux P
Afr Health; 1995 Nov; 18(1):20-2. PubMed ID: 12290565
[TBL] [Abstract][Full Text] [Related]
32. Kala-azar in Uttar Pradesh--a study of 66 patients.
Mittal V; Singh VK; Ichhpujani RL
J Commun Dis; 2002 Mar; 34(1):43-9. PubMed ID: 12718341
[TBL] [Abstract][Full Text] [Related]
33. Atypical disseminated leishmaniasis resembling post-kala-azar dermal leishmaniasis in an HIV-infected patient.
Boumis E; Chinello P; Della Rocca C; Paglia MG; Proietti MF; Petrosillo N
Int J STD AIDS; 2006 May; 17(5):351-3. PubMed ID: 16643688
[TBL] [Abstract][Full Text] [Related]
34. [Visceral leishmaniasis and human immunodeficiency virus (HIV) infection in the south of France].
Rosenthal E; Marty P; Cassuto JP
Presse Med; 1995 Nov; 24(35):1666. PubMed ID: 8545394
[No Abstract] [Full Text] [Related]
35. Disseminated cutaneous leishmaniasis after visceral disease in a patient with AIDS.
Calza L; D'Antuono A; Marinacci G; Manfredi R; Colangeli V; Passarini B; Orioli R; Varoli O; Chiodo F
J Am Acad Dermatol; 2004 Mar; 50(3):461-5. PubMed ID: 14988693
[TBL] [Abstract][Full Text] [Related]
36. [Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].
Pozio E
Parassitologia; 2004 Jun; 46(1-2):89-93. PubMed ID: 15305694
[TBL] [Abstract][Full Text] [Related]
37. [Fever of unknown origin in patients with HIV infection].
Riera M; Altés J; Homar F; Picco G; Salas A; Leyes M; Cifuentes C; Artigues A; Villalonga C
Enferm Infecc Microbiol Clin; 1996 Dec; 14(10):581-5. PubMed ID: 9052998
[TBL] [Abstract][Full Text] [Related]
38. [Leishmaniasis and human immunodeficiency virus infections].
Dedet JP; Lambert M; Pratlong F
Presse Med; 1995 Jun; 24(22):1036-40. PubMed ID: 7667232
[TBL] [Abstract][Full Text] [Related]
39. The histological spectrum of visceral leishmaniasis caused by Leishmania infantum MON-1 in acquired immune deficiency syndrome.
Hofman V; Marty P; Perrin C; Saint-Paul MC; Le Fichoux Y; Michiels JF; Glaichenhaus N; Pratlong F; Hofman P
Hum Pathol; 2000 Jan; 31(1):75-84. PubMed ID: 10665917
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of and factors associated with visceral leishmaniasis in human immunodeficiency virus type 1-infected patients in southern Spain.
Pineda JA; Gallardo JA; Macías J; Delgado J; Regordán C; Morillas F; Relimpio F; Martín-Sánchez J; Sánchez-Quijano A; Leal M; Lissen E
J Clin Microbiol; 1998 Sep; 36(9):2419-22. PubMed ID: 9705366
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
